Verification and validation of the anti-PD-L1 antibody, Clone 22C3 on a laboratory-developed test

Conclusions In conclusion, we propose to open for discussion the deconstruction of the current practice of a compulsory companion diagnostic test (CDT) for a particular PD-L1 immunohistochemical assay. The implementation of laboratory developed tests as an alternative to the CDT poses as a novel and readily available method to surmount limitations posed to pathology laboratories.
Source: Journal of Clinical Pathology - Category: Pathology Authors: Tags: Original research Source Type: research